PNPLA3 and metabolic dysfunction-associated steatotic liver disease: We have demonstrated a possible pathophysiologic mechanism of how the polymorphism I148M of the lipase PNPLA3 (for epidemiologic studies see [6,7,8]) may trigger NAFLD-progression on the molecular level.